Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Biomedical Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9434 Online ISSN: 2049-9442
Journal Cover
January-February 2015 Volume 3 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-February 2015 Volume 3 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Increased stathmin expression strengthens fear conditioning in epileptic rats

  • Authors:
    • Linna Zhang
    • Danni Feng
    • Hong Tao
    • Xiangyan De
    • Qing Chang
    • Qikuan Hu
  • View Affiliations / Copyright

    Affiliations: Department of Physiology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China, Department of Surgery, Ningxia Medical Clinical College, Yinchuan, Ningxia 750004, P.R. China, Department of Histoembryology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China
  • Pages: 28-32
    |
    Published online on: November 14, 2014
       https://doi.org/10.3892/br.2014.386
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Patients with temporal lobe epilepsy have inexplicable fear attack as the aura. However, the underlying neural mechanisms of seizure‑modulated fear are not clarified. Recent studies identified stathmin as one of the key controlling molecules in learning and innate fear. Stathmin binds to tubulin, inhibits microtubule assembly and promotes microtubule catastrophes. Therefore, stathmin is predicted to play a crucial role in the association of epilepsy seizures with fear conditioning. Firstly, a pilocarpine model of epilepsy in rats was established, and subsequently the fear condition training was performed. The epileptic rats with fear conditioning (epilepsy + fear) had a much longer freezing time compared to each single stimulus. The increased freezing levels revealed a significantly strengthened effect of the epileptic seizures on the learned fear of the tone‑shock contextual. Subsequently, the stathmin expression was compared in the hippocampus, the amygdale, the insular cortex and the temporal lobe. The significant change of stathmin expression occurred in the insular and the hippocampus, but not in the amygdale. Stathmin expression and dendritic microtubule stability were compared between fear and epilepsy in rats. Epilepsy was found to strengthen the fear conditioning with increased expression of stathmin and a decrease in microtubule stability. Fear conditioning slightly increased the expression of stathmin, whereas epilepsy with fear conditioning increased it significantly in the hippocampus, insular cortex and hypothalamus. The phosphorylated stathmin slightly increased in the epilepsy with fear conditioning. The increased expression of stathmin was contrary to the decrease of the stathmin microtubule‑associated protein (MAP2) and α‑tubulin in the epileptic rats with fear conditioning in all three areas of the brain. The most significant change of the ratio of MAP2 and α‑tubulin/stathmin occurred in the insular cortex and hippocampus. In conclusion, epilepsy can strengthen the fear conditioning with increased stathmin and decreased microtubule stability, particularly in the insular cortex and hippacampus. Therefore, the insular cortex may play a more important role between fear and epilepsy.

Introduction

The association between epilepsy and fear has attracted increasing attention alongside epilepsy research. Fear has been described as a crucial symptom of epilepsy, even in the oldest Chinese medical book. A large number of clinical cases of patients with temporal lobe epilepsy seizures often have inexplicable fear attack as the aura (1). Numerous patients reported the emotion of fear prior to seizures (2). Mesial temporal lobe epilepsy is commonly associated with ictal fear (3), and temporal lobectomy patients showed a general impairment in fear conditioning (4,5). However, the association between seizure-modulated fear and the underlying basics of neuronal mechanisms remains unclear.

Recent studies (6) identified stathmin as one of the key controlling molecules in learning and innate fear. Stathmin-knockout mice exhibit a decreased memory in amygdala-dependent fear conditioning and fail to recognize danger in innately aversive environments (7). The stathmin protein binds to tubulin and inhibits microtubule assembly and promotes microtubule catastrophes (8,9). Overexpression of stathmin can lead to disassembly of microtubules (10).

Therefore, stathmin is predicted to play a crucial role in associating the two processes; epilepsy seizures and fear conditioning. In the present study, the expression of stathmin in the epileptic rats was analyzed in detail with fear to confirm this hypothesis.

Materials and methods

Animals and epilepsy model

Adult male Sprague-Dawley rats (180–220 g) were used in the study. All the experimental procedures were approved by the Animal Research Committee of the Ningxia Medical University (Ningxia, China) and performed in accordance with the Chinese Animal Welfare Act for the use and care of laboratory animals. Rats were divided into four groups at random: Normal control (control), fear conditioning (fear), epilepsy (epilepsy) and epilepsy treated with fear groups (epilepsy + fear). The rats with epilepsy were triggered with pilocarpine and raised for 30 days after the epilepsy seizure. Each group comprised of six rats.

The epileptic model was established with LiCl/pilocarpine as previously described (10). The rats were injected intraperitoneally (IP) with LiCl (127 mg/kg) on day 1 and administered pilocarpine injection (30 mg/kg) 18–24 h later. Epileptic seizures of racine Ⅳ-V grade were chosen for the experiments. Epileptic rats were administered chloral hydrate (300 mg/kg) injection IP after 1 h of seizures to suppress the seizures. The normal control rats were administered the saline injection, respectively.

Fear conditioning and freezing time

The rats were placed in the conditioning chamber (23×23×35 cm) for 5 min before the loudspeaker stimulus. A sonic wave (1 min, 1,000 Hz, 75 Db) was delivered through the loudspeaker as the conditioned stimulus. Electrical foot shock (3 sec, 1 mA) stimulation occurred from the metal grid floor as the unconditioned stimulus. The context was a 1 min tone followed by the 3 sec foot shock, which was repeated 30 times (Fig. 1A). Following training in the chamber, the rats were returned to their home cages. The training was performed in 4 consecutive days. The rats of the fear and the epilepsy treated with fear groups underwent this training procedure. The control and the epilepsy groups had the same conditioned stimulus of the tone, but without the unconditioned electric stimulation at the foot shock.

Figure 1

Epilepsy strengthens the fear with a longer freezing time. The experimental animals were divided into four groups, with six rats in each group. The control group (control, ⅰ) and the epilepsy group (epilepsy, ⅲ) received only tone stimulus without the footshock. The fear group (fear, ⅱ) and the epilepsy + fear group (epilepsy + fear, ⅳ) received contextual tone and foot shock stimulus. (A) The scheme of the experiment. (B) The freezing time counted in the fear conditioning test (*F =4.521, P<0.05). The (C) serum corticosterone (COR) and (D) serum c-reactive protein (CRP) concentrations were analyzed. However, the changes did not show statistical significance when compared to the control.

Freezing time was used as an index of fear conditioning. Freezing was defined as immobility, excluding respiratory movements with a freezing posture. Rats remained still, sluggish, curled or crouched whilst breathing, and had a slight rocking motion. The total time of the freezing posture was called the freezing time and was measured starting from day 5 of training. The freezing time was measured immediately after the tone stimulation (without foot shock) and within 30 min. The behavioral activities were recorded by video.

Serum corticosterone (COR) and C-reactive protein (CRP) radioimmunoassay

The rats were anaesthetized and subsequentely decapitated to collect the whole blood with centrifuge tubes. Blood was incubated at 37̊C for 30 min. Serum was collected after 10 min centrifugation at 1,688 x g. Serum COR and CRP concentrations were measured by the radioimmunoassay kits, following the manufacturer's instructions. COR and hs-CRP radioimmunoassay kits were purchased from the Beijing Huaying Biotechnology Research Institute (Beijing, China). The radioimmunoassay was analyzed on the BN II Nephelometer (Dade Behring Marburg GmbH, Marburg, Germany) analyzer.

Brain tissue preparation, immunohistochemistry and western blotting

Brains were dissected and fixed routinely. A stainless steel rat brain matrix (175–300 g, coronal; RWD Life Science Co., Ltd., Shenzhen, China) was used to define the brain tissue blocks, including the hippocampus and insular cortex, respectively. A total of 15-µm coronal serial sections were prepared routinely. The boundary of the hippocampus and insular cortex was defined in accordance with the atlas of Paxinos and Watson (11). Ten sections, including the hippocampus or insular cortex, from each animal were chosen.

Immunohistochemistry was performed routinely. The stathmin protein 1 antibody (1:80; Proteintech, Inc., Chicago, IL, USA) and microtubule-associated protein (MAP2) antibodies (1:100; Bioworld, Visalia CA, USA) were used. The avidin-biotin kit (Zhongshan Golden Bridge Biotechnology Co., Ltd., Beijing, China) was used for the second antibody incubation and 3,3′-diaminobenzidine staining. All the sections were counterstained with hematoxylin. The immunohistochemistry-positivity of the images was assessed semi quantitatively by automatically measuring the optical densities.

Western blotting was performed routinely. Antibodies were used at the following concentrations: Stathmin 1 (1:300; cat no. ab47328); phosphorylated stathmin 1 (1:500; cat no. ab47398; Abcam, Cambridge, MA, USA); microtubule-associated protein (1:800; cat no. 17490-1-AP; Bioworld); α-tubulin (1:5,000; cat no. 66031-1-Ig Proteintech); GAPDH (1:5,000; cat no. TA-08; Bioss, Beijing, China); and horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin G (cat no. ZB-2301; ZSGB-BIO, Beijing, China). Quantization of relative band densities was performed by scanning densitometry.

Statistical analysis

All the data were processed using SPSS 17.0 software (SPSS, Inc., Chicago, IL, USA). Mean ± standard deviation that the measurement data using one-way ANOVA; same object point in time measurement data using a repeated measures analysis of variance. P<0.05 was considered to indicate a statistically significant difference.

Results

Fear is strengthened following epilepsy

Rats (n=6) in the normal control exhibited an extremely short freezing time, from 2 to 14 sec, with an average of 5 sec. Whereas the epileptic rats (n=6, and epilepsy after 30 days) had a longer freezing time, from 10 to 152 sec, with an average of 36 sec, which was ~5–6-fold longer compared to the normal control (Fig. 1B).

Rats with fear training by tone and foot shock (fear) only (n=6) exhibited an increased freezing time immediately following the shock, from 15 to 152 sec, with an average of 74 sec. This was ~10–12-fold longer compared to the control and ~2-fold longer compared to the epilepsy group. Therefore, the contextual fear has occurred in these rats (F=4.521, P<0.05).

The rats of the epilepsy + fear (n=6) group had the longest freezing time among the four groups. The average freezing time was 203 sec, which was approximately three times higher compared to the fear group. As these rats have experienced epileptic seizures during the past 30 days, the increased freezing time revealed a significantly strengthened effect of epileptic seizures on the learned fear of the tone-shock contextual. These results indicate that these rats not only have the memory regarding the context in which they received the electrical stimulation, but have also developed a strong aversive response to the tone and the environment associated with a painful experience.

Systemic stress responses increase accompanied epilepsy and fear

Psychological processes, such as fear, are always accompanied with systemic stress responses. A systemic stress response includes objective signs of stress, such as high serum levels of adrenocorticotropic and cortisol, elevation of immunoreactions and an increase in arterial blood pressure (12). In the present study, the serum COR and inflammatory biomarker, CRP, were chosen as the biological indices of psychological stress caused by the fear.

The COR and CRP levels of the fear and the epilepsy + fear rats elevated when compared to the control. However, there was no statistical significance when compared to the control (Fig. 1C and D).

Epilepsy and fear increase the expression of stathmin

According to the results of the western blotting, as shown in Fig. 2, the expression of stathmin in the three areas of the brain increased in a similar sequence. The highest expression of stathmin was observed in the epilepsy + fear rats. Fear conditioning (the fear group) increased the expression of stathmin slightly, whereas the epilepsy + fear treatment increased it dramatically. The stathmin expression level of the epilepsy group was also significantly increased, more than that of the fear group, particularly in the insular cortex and hypothalamus, but less in the hippocampus (insula F=75.863, P<0.05; hippocampus F=36.698, P<0.05; and hypothalamus F=150.761, P<0.05).

Figure 2

Epilepsy and fear increased the stathmin expression. The expression of total proteins were examined by western blotting. The relative expression of stathmin, microtubule-associated protein (MAP2) and α-tubulin were standardized to GAPDH, respectively. (A and B) Three areas of the brain were analyzed; insular cortex, hippocampus and hypothalamus. (C) The ratio of MAP2 and α-tubulin/stathmin was calculated to indicate the microtubule stability.

Stathmin is a phospho-protein that binds to tubulin and regulates microtubule dynamics. The binding of stathmin to tubulin and its ability to disrupt the microtubules is modulated through its phosphorylation on multiple serine residues. These microtubule destabilizing activities are suppressed by phosphorylation of stathmin (9). Therefore, the expression levels of phosphorylated stathmin were examined by western blotting. The phosphorylated stathmin increased slightly in the epilepsy + fear conditioning rats, in all three areas of the brain. The increasing effects on phosphorylated stathmin were stronger in the epilepsy group compared to the fear group, suggesting that phosphorylated stathmin was more sensitive in the epileptic brain to the contextual stimulus of tone.

Western blotting analysis revealed that the expression of MAP2 decreased inversely with stathmin in the epilepsy and the fear groups in all three areas of the brain. The most significant decrease was observed in the epilepsy + fear group (Fig. 2). The expression of α-tubulin was not significantly changed in all the groups and in all three areas of the brain.

The microtubule stability was indicated by the ratio of MAP2 and α-tubulin/stathmin. In all three areas of the brain tested, epilepsy + fear had the lowest ratio, indicating that the microtubule stability was lowest. The most evident change of this ratio occurred in the insular cortex, instead of the hippocampus (Fig. 2).

Stathmin expression peaks at 30 days after epileptic seizures

To further analyze the variation of stathmin expression during the development of epilepsy, the immunohisotochemical patterns in the temporal cortex and the hippocampus were examined at 3, 30 and 60 days after the epileptic seizures. The stathmin expression started to increase at 3 days and reached its peak after 30 days of epilepsy in the local areas of the insular cortex. The reinforced stathmin expression in the dendrites was even more noticeable in the local areas of the insular, which was located at the IV layer of the cortex. Evident variation patterns were also observed in the hippocampus CA2 region, but not in the amygdale and temporal lobe cortex (Fig. 3). Stathmin expression declined to the normal control level in 60 days, in all the areas tested (insula F=52.018, P<0.05; hippocampus F=42.074, P<0.05; amygdala F=12.699, P<0.05; and temporal lobe F=21.469, P<0.05).

Figure 3

Stathmin reached its peak in the insular after 30 days of epilepsy. Three time points were tested after the epilepsy seizures; days 3, 30 and 60. (A) Images shown here focused at the II-IV layers of the insular cortex, the temporal lobe cortex, the CA2 region of the hippocampus and the amygdale. (B) The immuno-positivity of the images was assessed semi-quantitatively by automatically measuring the optical densities of three images at each time point. The statistically significant different areas are shown as * P<0.05, compared to their control in the insular (*F =52.018); hippocampus CA2 region (*F =42.074); amygdale (*F =12.699); and temporal lobe (*F =21.469).

Discussion

Epileptic seizures can lead to psychological deficits, including learning and memory deficits, fear, language impairment and depression. In certain temporal lobe epileptic patients, intense ictal fear was the main feature of epileptic seizures (14). The present study confirmed that epilepsy can strongly aggravate or strengthen the fear conditioning and makes the epileptic rats more sensitive to the fear stimulation, as demonstrated by a longer freezing time.

Stathmin is essential for regulation of the innate and learned fear. Those rats with a longer freezing time exhibited a higher expression level of stathmin. Epilepsy alone, without the fear conditioning, has certain increasing effects on stathmin expression, which reached its peak at 30 days after seizure, particularly in the insular instead of the hippocampus.

Microtubules and cytoskeleton play crucial roles during the neuronal processes of epilepsy and fear (15). Stathmin strongly increases the minus end catastrophe frequency and induces rapid treadmilling of bovine brain microtubules (16). The MAP2 expression decreased inversely with the increase of stathmin. This result indicates that the microtubule stability plays a crucial role in the epilepsy associated fear conditioning.

The insular lobe has also been shown to generate interictal and ictal discharges in the majority of temporal lobe epileptic patients analyzed with depth electrodes positioned in this area (17). In the present study, the most evident changes of stathmin expression occurred in the insular cortex and the hippocampus, instead of the amygdale. This result suggests that the insular cortex may play a more important role in the correlation of fear and epilepsy.

In conclusion, epilepsy can strongly aggravate the sensation of fear, as exhibited by a longer freezing time. This is evidenced by an increase in stathmin expression and an inverse decrease of microtubule stability, particularly in the insular cortex.

Acknowledgements

The present study was supported by grants from the Chinese National 973 Projects (nos. 2011CB512115 and 2012CB722408) to Tao Sun, the National Natural Science Foundation of China (nos. 30960150 and 31260246) to Qikuan Hu, the Natural Science Foundation of Ningxia (no. NZ12172) to Linna Zhang and the Funds of Ningxia Medical University (no. XT200909) to Qikuan Hu.

References

1 

Chiesa V, Gardella E, Tassi L, Canger R, Lo Russo G, Piazzini A, Turner K and Canevini MP: Age-related gender differences in reporting ictal fear: analysis of case histories and review of the literature. Epilepsia. 48:2361–2364. 2007.PubMed/NCBI

2 

Ryan S and Räisänen U: ‘The brain is such a delicate thing’: an exploration of fear and seizures among young people with epilepsy. Chronic Illn. 8:214–224. 2012. View Article : Google Scholar

3 

Reynders HJ, Broks P, Dickson JM, Lee CE and Turpin G: Investigation of social and emotion information processing in temporal lobe epilepsy with ictal fear. Epilepsy Behav. 7:419–429. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Weike AI, Hamm AO, Schupp HT, Runge U, Schroeder HW and Kessler C: Fear conditioning following unilateral temporal lobectomy: dissociation of conditioned startle potentiation and autonomic learning. J Neurosci. 25:11117–111124. 2005. View Article : Google Scholar

5 

Hlobil U, Rathore C, Alexander A, Sarma S and Radhakrishnan K: Impaired facial emotion recognition in patients with mesial temporal lobe epilepsy associated with hippocampal sclerosis (MTLE-HS): Side and age at onset matters. Epilepsy Res. 80:150–157. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Zhang L.-Ν..LI H.-Υ..Tao H..HU Q.-Κ.: Expression of stathmin gene in brain of epilepsy rats. ShanDong Med. 41:24–28. 2012.(In Chinese).

7 

Shumyatsky GP, Malleret G, Shin RM, Takizawa S, Tully K, Tsvetkov E, Zakharenko SS, Joseph J, Vronskaya S, Yin D, Schubart UK, Kandel ER and Bolshakov VY: Stathmin, a gene enriched in the amygdala, controls both learned and innate fear. Cell. 123:697–709. 2005. View Article : Google Scholar : PubMed/NCBI

8 

Niethammer P, Bastiaens P and Karsenti E: Stathmin-tubulin interaction gradients in motile and mitotic cells. Science. 303:1862–1866. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V, Siavoshian S, Maucuer A and Sobel A: Stathmin and its phosphoprotein family: general properties, biochemical and functional interaction with tubulin. Cell Struct Funct. 24:345–357. 1999. View Article : Google Scholar : PubMed/NCBI

10 

Cassimeris L: The oncoprotein 18/stathmin family of microtubule destabilizers. Curr Opin Cell Biol. 14:18–24. 2002. View Article : Google Scholar

11 

Glien M, Brandt C, Potschka H, Voigt H, Ebert U and Löscher W: Repeated low-dose treatment of rats with pilocarpine: low mortality but high proportion of rats developing epilepsy. Epilepsy Res. 46:111–119. 2001. View Article : Google Scholar : PubMed/NCBI

12 

Paxinos G and Watson C: The Rat brain in Stereotaxic Coordinates. 3rd. Academic Press; Sydney: pp. 51–73. 2007

13 

Dockray S and Steptoe A: Positive affect and psychobiological processes. Neurosci Biobehav Rev. 35:69–75. 2010. View Article : Google Scholar

14 

Biraben A, Taussig D, Thomas P, Even C, Vignal JP, Scarabin JM and Chauvel P: Fear as the main feature of epileptic seizures. J Neurol Neurosurg Psychiatry. 70:186–191. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Gardiner J and Marc J: Disruption of normal cytoskeletal dynamics may play a key role in the pathogenesis of epilepsy. Neuroscientist. 16:28–39. 2010. View Article : Google Scholar : PubMed/NCBI

16 

Manna T, Thrower D, Miller HP, Curmi P and Wilson L: Stathmin strongly increases the minus end catastrophe frequency and induces rapid treadmilling of bovine brain microtubules at steady state in vitro. J Biol Chem. 281:2071–2078. 2006. View Article : Google Scholar

17 

Isnard J, Guénot M, Sindou M and Mauguière F: Clinical manifestations of insular lobe seizures: a stereo-electroencephalographic study. Epilepsia. 45:1079–1090. 2004. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang L, Feng D, Tao H, De X, Chang Q and Hu Q: Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomed Rep 3: 28-32, 2015.
APA
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., & Hu, Q. (2015). Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomedical Reports, 3, 28-32. https://doi.org/10.3892/br.2014.386
MLA
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., Hu, Q."Increased stathmin expression strengthens fear conditioning in epileptic rats". Biomedical Reports 3.1 (2015): 28-32.
Chicago
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., Hu, Q."Increased stathmin expression strengthens fear conditioning in epileptic rats". Biomedical Reports 3, no. 1 (2015): 28-32. https://doi.org/10.3892/br.2014.386
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang L, Feng D, Tao H, De X, Chang Q and Hu Q: Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomed Rep 3: 28-32, 2015.
APA
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., & Hu, Q. (2015). Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomedical Reports, 3, 28-32. https://doi.org/10.3892/br.2014.386
MLA
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., Hu, Q."Increased stathmin expression strengthens fear conditioning in epileptic rats". Biomedical Reports 3.1 (2015): 28-32.
Chicago
Zhang, L., Feng, D., Tao, H., De, X., Chang, Q., Hu, Q."Increased stathmin expression strengthens fear conditioning in epileptic rats". Biomedical Reports 3, no. 1 (2015): 28-32. https://doi.org/10.3892/br.2014.386
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team